CDH2 and familial pancreatic carcinoma: Functional analysis showed that NR3C2 may inhibit pancreatic cancer cell metastasis by reducing EMT, with an induction in E-cadherin and a decrease in ZEB1, N-cadherin, and vimentin (18, 23).